AzTrials
AzTrials

Gait Impairment in Stroke PatientsNCT07034105

Spatiotemporal Gait Parameters of Healthy and Stroke Patients During Overground, Treadmill, and Body Weight Supported Treadmill Walking

A study testing Gait Analysis in people with Gait Impairment in Stroke Patients, run by Bangladesh University of Engineering and Technology at 1 site in Bangladesh.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Gait impairments following a stroke significantly hinder mobility and quality of life, emphasizing the need for precise assessment methods to guide effective rehabilitation strategies. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Gait Impairment in Stroke Patients
What is being tested?
Gait Analysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteBangladesh
Study dates
12 Jun 2024to 11 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must be between 18 to 75 years old.
  • More than 1- month post stroke patient.
  • Participants must be able to walk with or without assistance.
  • Patients including both the male and female.
  • Participants must be able to provide informed consent to participate in the study.

Who cannot join

  • Severe cognitive or communicative disorders.
  • Significant joint malposition.
  • Psychological, cognitive dysfunction, and any other neuromuscular problem.
  • Pregnant women will be excluded to avoid any potential risks to the mother and fetus.
  • Unstable cardiovascular disease like congenital heart disease, deep vein thrombosis, coronary heart disease, previous history of heart attack or heart failure.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Muhammad Tarik Arafat, PhD contact

01911764467

tarikarafat@bme.buet.ac.bd

Mehedi Hasan Prince, B.Sc. contact

+8801745676375

mhprince.bme@gmail.com

Bangladesh1 site, 1 recruiting
  • Bangladesh University of Engineering and Technology

    Dhaka, 1000

    Muhammad Tarik Arafat, PhD, +88 01911764467, tarikarafat@bme.buet.ac.bd

    Recruiting

Other trials in Bangladesh

About this study

Official title: Variability in Spatiotemporal Gait Parameters of Stroke Patients Across Overground, Self Paced Treadmill, and Body-Weight Supported Treadmill Walking

Gait impairments following a stroke significantly hinder mobility and quality of life, emphasizing the need for precise assessment methods to guide effective rehabilitation strategies. This study evaluates the variability and reliability of spatiotemporal gait parameters across three walking modalities: overground walking, treadmill walking, and body-weight-supported treadmill walking. Using a counterbalanced design, all participants undergo gait analysis in each modality to ensure unbiased and reliable comparisons.

The study also incorporates a locally developed, cost-effective Body Weight Support System (BWSS) to address the limitations of accessibility in resource-constrained settings. By identifying how different modalities influence gait variability and reliability, this research aims to optimize rehabilitation outcomes and demonstrate the feasibility of implementing affordable gait analysis tools in clinical practice.

Read the detailed description

Stroke remains a leading cause of long-term disability, with gait impairments being a prominent challenge that significantly affects functional independence. Accurate and reliable assessment of gait parameters is crucial for tailoring rehabilitation interventions. This study investigates the variability and reliability of spatiotemporal gait parameters, such as stride length, cadence, step time, and gait variability, across three distinct walking modalities:

  1. Overground walking
  2. Self paced treadmill walking
  3. Body weight supported treadmill walking The study employs a counterbalanced design, where each participant performs all three walking modalities, mitigating potential order effects and ensuring robust and reproducible comparisons. Advanced motion analysis systems are utilized to capture high-resolution data, providing insights into the dynamic interplay of gait variability and reliability under each condition.

A key innovation of this study is the use of an in-house, cost-effective Body Weight Support System (BWSS). Unlike commercially available systems, which are often prohibitively expensive, the BWSS is designed for accessibility in resource-limited settings, enabling widespread clinical and research applications. This approach aligns with the study's broader goal of improving healthcare equity by developing practical solutions tailored to local needs.

By analyzing the impact of different walking modalities on gait, the research aims to:

  1. To analyze the variability and reliability of spatiotemporal gait parameters in stroke patients across overground, treadmill, and body weight supported treadmill walking (BWST). ii. To identify the walking modality that exhibits the most consistent and stable gait metrics. iii. To assess the clinical relevance of gait parameters from different walking modalities to optimize stroke rehabilitation interventions.

This research not only advances the understanding of stroke rehabilitation but also contributes to the global effort to make cutting-edge medical technologies accessible to underserved populations.

Being tested
Gait Analysis
Keywords
Gait Analysis, Spatiotemporal Parameters, Body Weight Support System (BWSS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait AnalysisDiagnostic test

    • Overground Walking: Stroke patients walk in a natural environment, collecting data on their gait parameters such as stride length, cadence, and gait speed.
    • Treadmill: Patients walk on a treadmill at their comfortable pace, allowing for more control over their walking speed while measuring the same gait parameters as in overground walking.
    • Body-Weight Supported Treadmill: Patients walk on a treadmill with a body-weight support system that reduces the load on the legs, enabling patients with more severe impairment to perform walking tasks safely while recording gait parameters.
Study groups in NCT07034105
Study groupRoleWhat they receive
Experimental Group - Walking Modalities ComparisonExperimentalThis arm will involve stroke patients who undergo all three walking modalities (Overground Walking, Self-Paced Treadmill, and Body-Weight Supported Treadmill) in a counterbalanced order. Each patient will perform all modalities, and the spatiotemporal gait parameters such as stride length, cadence, and gait speed will be measured for analysis. The primary goal is to compare gait parameter variability and reliability across different walking conditions, assessing the effect of each modality on stroke rehabilitation.
Receives: Diagnostic Test: Gait Analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Spatiotemporal Gait Parameter Variability

    The primary outcome measure will be the variability of spatiotemporal gait parameters, including stride length, cadence, and gait speed, assessed during the three walking modalities (Overground, treadmill, and body weight supported treadmill). The variability will be analyses by calculating the standard deviation and coefficient of variation for each parameter across all walking conditions. These measures will reflect the stability and consistency of the patients' gait performance in different walking settings, which is crucial for understanding their rehabilitation progress and the effect of each walking modality on recovery.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2025
  2. Study start12 Jun 2024
  3. Primary completion11 Jul 2025 (estimated)
  4. Study completion11 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07034105
Sponsor's protocol ID
BUET/ERC/2024/02
Status last verified
Jun 2025
First submitted
19 Apr 2025
Last updated
24 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Gait Analysis in people with Gait Impairment in Stroke Patients, run by Bangladesh University of Engineering and Technology at 1 site in Bangladesh.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Bangladesh. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Muhammad Tarik Arafat, PhD (01911764467, tarikarafat@bme.buet.ac.bd), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Spatiotemporal Gait Parameter Variability (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in